Health
Lilly Cuts Price of Zepbound Vials to Battle Cheaper Copycats
This article is for subscribers only.
Eli Lilly & Co. is ramping up the fight against cheaper, copycat versions of Zepbound by lowering prices for a version of its blockbuster obesity drug.
The company is reducing the cost of its 2.5 milligram and 5 milligram Zepbound vials to $349 and $499 a month, respectively, according to a statement. That’s about $50 less than current prices.